HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M V Cohen Selected Research

4- (7- ((2- 3- chloro- 2- thienyl)- 1- methyl- propylamino)- 3H- imidazo(4,5- b)pyridyl- 3- yl)cyclopentane carboxamide

12/2001Attenuation of oxidant stress during reoxygenation by AMP 579 in cardiomyocytes.
9/2001Amp 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors.
12/2000Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M V Cohen Research Topics

Disease

15Ischemia
06/2004 - 01/2000
14Infarction (Infarctions)
09/2007 - 02/2000
2Myocardial Infarction
09/2007 - 12/2000
2Reperfusion Injury
12/2001 - 12/2000
1Neutropenia
11/2012
1Myocardial Reperfusion Injury
12/2001
1Contracture
09/2001
1Weight Loss (Weight Reduction)
02/2001
1Body Weight (Weight, Body)
02/2001
1Necrosis
12/2000
1Wounds and Injuries (Trauma)
12/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
12/2000

Drug/Important Bio-Agent (IBA)

5Adenosine (Adenocard)FDA LinkGeneric
12/2001 - 01/2000
5triphenyltetrazoliumIBA
11/2001 - 07/2000
34- (7- ((2- 3- chloro- 2- thienyl)- 1- methyl- propylamino)- 3H- imidazo(4,5- b)pyridyl- 3- yl)cyclopentane carboxamideIBA
12/2001 - 12/2000
3Protein Kinase CIBA
11/2001 - 01/2000
3Adenosine Triphosphate (ATP)IBA
11/2001 - 09/2000
3Free RadicalsIBA
11/2001 - 09/2000
3BuffersIBA
09/2001 - 12/2000
3p38 Mitogen-Activated Protein KinasesIBA
08/2001 - 02/2000
3Phosphotransferases (Kinase)IBA
09/2000 - 01/2000
2Ethanol (Ethyl Alcohol)IBA
11/2001 - 02/2001
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2001 - 09/2000
2Free Radical ScavengersIBA
08/2001 - 08/2001
25-hydroxydecanoic acidIBA
08/2001 - 09/2000
2SB 203580IBA
08/2001 - 12/2000
2Pharmaceutical PreparationsIBA
12/2000 - 07/2000
2GenisteinIBA
09/2000 - 02/2000
2ElementsIBA
06/2000 - 01/2000
1pegfilgrastim (Neulasta)FDA Link
11/2012
1Filgrastim (Neupogen)FDA Link
11/2012
1Anti-Bacterial Agents (Antibiotics)IBA
11/2012
1TaurineFDA Link
06/2004
1Oxidants (Oxidizing Agents)IBA
12/2001
1Protein Kinase C-epsilonIBA
11/2001
1Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA
09/2001
18-(3-chlorostyryl)caffeineIBA
09/2001
1Adenosine A2 ReceptorsIBA
09/2001
11,3-dipropyl-8-cyclopentylxanthineIBA
09/2001
1Acetylcholine (Acetylcholine Chloride)FDA Link
08/2001
1Glycine (Aminoacetic Acid)FDA LinkGeneric
08/2001
1Vitamin K 3 (Menadione)FDA Link
08/2001
1myxothiazolIBA
08/2001
1mitochondrial K(ATP) channelIBA
04/2001
1ChloridesIBA
12/2000
1AcidsIBA
12/2000
14,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA
12/2000
1Purinergic P1 Receptors (Adenosine Receptor)IBA
12/2000
1N- ((1S,trans)- 2- hydroxycyclopentyl)adenosineIBA
12/2000
1Adenosine A1 ReceptorIBA
12/2000
15-nitro-2-(3-phenylpropylamino)benzoic acidIBA
12/2000
1MK 473IBA
12/2000
1Purinergic P1 Receptor AgonistsIBA
12/2000
1Adenosine A1 Receptor AgonistsIBA
12/2000
1chelerythrineIBA
09/2000
1Diazoxide (Hyperstat)FDA Link
09/2000
1S-Nitroso-N-AcetylpenicillamineIBA
07/2000
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
07/2000
1Nitric Oxide Synthase (NO Synthase)IBA
07/2000
1MAP-kinase-activated kinase 2IBA
02/2000
1AnisomycinIBA
02/2000
1BradykininIBA
01/2000
1Opioid Analgesics (Opioids)IBA
01/2000
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2000

Therapy/Procedure

2Therapeutics
11/2012 - 09/2007
1Drug Therapy (Chemotherapy)
11/2012
1Stem Cell Transplantation
11/2012
1Ischemic Postconditioning
09/2007
1Bariatric Surgery
02/2001
1PC protocol
07/2000